Physician
Chesapeake Urology Associates, LLC
Chesapeake Urology Associates, LLC was paid $3.68M by Medicaid between Jan 2018 and Dec 2024, across 60 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 20% of everything it billed.
33Billing provider infoCHESAPEAKE UROLOGY ASSOCIATES, LLC
OWINGS MILLS, MD 21117
OWINGS MILLS, MD 21117
33aNPI1609823004assigned 05/30/2006
33bProvider typeHematology & Oncology Physician
28Total paid$3.68M
24GClaims198,924
24DCodes billed60
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in Maryland
Rank by total paid#2 of 30
Median peer was paid$116K
This provider vs. median32×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,807 | $664K | |
| 2019 | 19,253 | $465K | |
| 2020 | 18,263 | $363K | |
| 2021 | 22,202 | $556K | |
| 2022 | 34,363 | $543K | |
| 2023 | 46,350 | $584K | |
| 2024incomplete | 38,686 | $506K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 26,417 | 18,534 | $753K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 29,385 | 22,180 | $530K |
| 81003 | 10% | 48,663 | 34,186 | $384K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 7.7% | 6,609 | 5,027 | $282K |
| J0897 | Injection, denosumab, 1 mg | 5.9% | 1,121 | 780 | $216K |
| 36415 | Collection of venous blood by venipuncture | 5.2% | 11,716 | 8,794 | $192K |
| 52000 | 4.3% | 4,717 | 4,032 | $160K | |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 2.8% | 1,462 | 980 | $103K |
| 76775 | 2.7% | 6,051 | 4,586 | $101K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 2.7% | 1,625 | 851 | $99K |
| 64566 | 2.6% | 838 | 428 | $97K | |
| 51798 | 2.3% | 11,518 | 9,046 | $86K |
48 more codes
| 51705 | 2.3% | 3,518 | $84K | |
| 99203 | Doctor's office visit, new patient (routine) | 2.1% | 3,847 | $77K |
| 51728 | 1.4% | 393 | $50K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1.1% | 2,308 | $39K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 1.1% | 6,383 | $39K |
| 51702 | 1.0% | 2,000 | $37K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 2,491 | $36K |
| 76770 | <1% | 1,803 | $28K | |
| 51700 | <1% | 1,018 | $27K | |
| 88112 | <1% | 432 | $25K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 2,915 | $24K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 1,368 | $19K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,683 | $18K |
| 99490 | Ccm add 20min | <1% | 3,217 | $18K |
| 99223 | Prolong inpt eval add15 m | <1% | 939 | $17K |
| 99439 | <1% | 1,083 | $17K | |
| 96402 | <1% | 2,660 | $15K | |
| 51797 | <1% | 440 | $15K | |
| J9155 | Injection, degarelix, 1 mg | <1% | 227 | $14K |
| 76857 | <1% | 1,766 | $13K | |
| 52356 | <1% | 38 | $8K | |
| 76872 | <1% | 455 | $8K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 109 | $5K |
| 52310 | <1% | 226 | $5K | |
| 88121 | <1% | 14 | $5K | |
| 55700 | <1% | 139 | $4K | |
| 52332 | <1% | 107 | $4K | |
| 96401 | <1% | 326 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,246 | $3K |
| 51703 | <1% | 277 | $3K | |
| 52287 | <1% | 124 | $3K | |
| 74420 | <1% | 74 | $3K | |
| 51784 | <1% | 437 | $3K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 127 | $2K |
| 99489 | Ccm add 20min | <1% | 48 | $2K |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | <1% | 16 | $1K |
| 99243 | <1% | 20 | $697.98 | |
| 99406 | <1% | 58 | $585.06 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 123 | $383.22 |
| 82570 | <1% | 30 | $107.87 | |
| 99221 | <1% | 12 | $22.76 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 14 | $6.48 |
| 99487 | Ccm add 20min | 0% | 48 | $0.00 |
| 99426 | 0% | 1,112 | $0.00 | |
| 99427 | 0% | 114 | $0.00 | |
| 51729 | 0% | 58 | $0.00 | |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 0% | 40 | $0.00 |
| 51741 | 0% | 1,919 | $-1033.63 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSKLAR, GEOFFREY (AUTHORIZED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Arizona Urology Specialists, PLLC | Phoenix, AZ | $1.08M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.